Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024
Rapid Micro Biosystems (Nasdaq: RPID), a life sciences technology company specializing in automation solutions for efficient healthcare product manufacturing, has announced its plans to release second quarter 2024 financial results before the market opens on Friday, August 2, 2024. Following the release, the company's management team will host a webcast conference call at 8:30 a.m. ET on the same day.
Investors and interested parties can access the live webcast through the company's website. The webcast will remain available for replay for one year after the event. This announcement provides an opportunity for stakeholders to gain insights into Rapid Micro Biosystems' financial performance and future outlook.
- None.
- None.
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2024 financial results prior to the market open on Friday, August 2, 2024.
In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Friday, August 2, 2024. The live webcast will be accessible on the Company’s website here and will be available for replay for one year from the webcast date.
About Rapid Micro Biosystems
Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct System automates and modernizes the antiquated, manual MQC testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct System brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Lexington, Massachusetts, Switzerland, Germany, and the Netherlands.
For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn.
FAQ
When will Rapid Micro Biosystems (RPID) release its Q2 2024 financial results?
What time is the Q2 2024 earnings call for Rapid Micro Biosystems (RPID)?
How can I access Rapid Micro Biosystems' (RPID) Q2 2024 earnings webcast?
What does Rapid Micro Biosystems (RPID) specialize in?
